Covid-19 Pharma Insights
Moderna v Pfizer-BioNTech: Lessons to be learnt from post-pandemic disputes
Dr. Nicholas Jones, partner and patent attorney at Withers & Rogers, discusses what the pharma industry can learn from its experiences of working collaboratively during the COVID-19 pandemic by establishing best practice and minimising risks.
13 Sep 2022
Using genomic sequencing to predict COVID’s next move
Brittany Niccum, Beckman Coulter Life Sciences, shares how genomic sequencing and laboratory automation can monitor new variants of COVID and potentially nip them in the bud, before they transform into future pandemics.
17 Aug 2022
Wastewater is anything but a waste: It could even prevent the next pandemic
Ari Goldfarb, CEO, Kando, discusses how innovative technologies and artificial intelligence tools are advancing wastewater analysis and could potentially mitigate the effects, or even prevent, future pandemics.
26 Jul 2022
![Iceni Diagnostics lab work3[56] copy.jpg](https://pharmaceuticalmanufacturer.media/downloads/8735/download/Iceni%20Diagnostics%20lab%20work3%5B56%5D%20copy.jpg?cb=721e8ffb3ddfd1aa0d648b6943b50db1&w=640 "Iceni Diagnostics lab work3[56] copy.jpg")
Opinion: Pandemic preparedness
Martin Stocks, CEO of Iceni Glycoscience, discusses how preparedness for the pandemic relies on leveraging the technologies and insights of innovative startups.
25 May 2022
The MedTalk Podcast - How iiCON is driving innovation in the UK and beyond
We speak to professor Janet Hemingway, the founding director of the Infection Innovation Consortium (iiCON) to find out all about the work the organisation has done throughout the Covid-19 pandemic.
1 Feb 2022
The future of Covid-19 vaccinations
Ivor Campbell managing director of Snedden Campbell discusses the future of Covid-19 vaccination and why testing is crucial amidst falling antibody levels.
30 Nov 2021
![Iceni Diagnostics lab work3[56] copy.jpg](https://pharmaceuticalmanufacturer.media/downloads/8735/download/Iceni%20Diagnostics%20lab%20work3%5B56%5D%20copy.jpg?cb=721e8ffb3ddfd1aa0d648b6943b50db1&w={width}&h={height} "Iceni Diagnostics lab work3[56] copy.jpg")
PeopleImages.com - Yuri A Shutterstock
COVID-19 infection and some COVID-19 vaccines tied to risk of neurological disorder
A large-scale international study involving researchers from the Drug Safety Research Unit (DSRU), UK, highlights the relationship between SARS-CoV-2 infection, certain COVID-19 vaccines, and Guillain-Barré syndrome (GBS).
9 Jun 2025
Shutterstock
PrecisionLife and Metrodora Institute Partner
PrecisionLife and Metrodora Institute are co-investing in a first-of-its-kind partnership to jumpstart the diagnosis and treatment options for a range of complex, chronic diseases including Long COVID, ME/CFS, ALS, Sjögren's syndrome, and many more.
26 Feb 2024
Shutterstock
Osivax Announce First-in-Human Phase 1 Vaccination Trial
Osivax have announced that the first participant has been vaccinated in its new Phase 1 trial (NCT06128382) evaluating OVX033, a broad-spectrum sarbecovirus vaccine candidate.
15 Feb 2024
Sponsored Content
White Raven sets new standards for achieving GMP certification
Download the Playbook to learn how White Raven reached GMP certification in just 18 months.
Holistic IP strategy is needed for ‘off-the-shelf’ CAR T cell therapies
With so much investor interest surrounding the potential of allogeneic CAR T cell therapies, the stakes are high for innovators to ensure that their inventions are robustly protected from the start.
6 Nov 2025
Boehringer Ingelheim
Applying AI in patient safety use cases
What’s the best way to introduce AI to enhance automation of high-volume pharmacovigilance activities, such as adverse event case intake and processing?
5 Nov 2025
Tjoapack
Driving the revolution in packaging
Geert Vleugels, general manager at Tjoapack discusses the revolution in packaging.
4 Nov 2025
Olivia Friett
Were CPHI Frankfurt 2025 expectations met?
European Pharmaceutical Manufacturer asked various leaders in pharma what the highlights of CPHI 2025 were and if the event met expectations.
3 Nov 2025
BMG
Navigating complex regulatory landscapes
Rachel Houghton, managing director at Business Moves Group (BMG), explores how pharmaceutical manufacturers can navigate complex regulatory landscapes and safeguard sensitive equipment to ensure seamless international workplace transitions.
30 Oct 2025
Sirio Pharma
Using pharma-grade quality control in nutraceuticals
Kayla Pham, vice president of quality at Best Formulations/Sirio Pharma shares why more and more, nutrition and nutraceuticals brand owners are placing pharma-grade quality control atop their manufacturing partnership wish lists.
30 Oct 2025
Pharmaceutical Insights + Pharmaceutical Manufacturing Insights
Sponsored Content
Stevanato Group
A one-stop shop for even the most challenging Monoclonal Antibodies (mAbs)
The biologics market is expanding rapidly – with a compound annual growth rate of 15% predicted until 2027. But this new generation of drugs comes with unique challenges that require an innovative approach underpinned by extensive experience.
12 Mar 2025
08:00
Sponsored Content
White Raven sets new standards for achieving GMP certification
Download the Playbook to learn how White Raven reached GMP certification in just 18 months.
Sponsored Content
Stevanato Group
A one-stop shop for even the most challenging Monoclonal Antibodies (mAbs)
The biologics market is expanding rapidly – with a compound annual growth rate of 15% predicted until 2027. But this new generation of drugs comes with unique challenges that require an innovative approach underpinned by extensive experience.
12 Mar 2025
08:00